Panagora Asset Management Inc Exact Sciences Corp Transaction History

Panagora Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $13,331 - $20,587	417 Added 5.73%	7,698 $250,000
Q1 2022 May 12, 2022	BUY	$57.56 - $82.54 $18,591 - $26,660	323 Added 4.64%	7,281 $509,000
Q3 2021 Nov 10, 2021	SELL	$90.24 - $124.05 $85,547 - $117,599	-948 Reduced 11.99%	6,958 $664,000
Q2 2021 Aug 11, 2021	BUY	$93.66 - $139.27 $327,060 - $486,330	3,492 Added 79.11%	7,906 $983,000
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $250,042 - $332,496	2,145 Added 94.54%	4,414 $582,000
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $131,584 - $187,740	1,321 Added 139.35%	2,269 $301,000
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $35,949 - $50,290	493 Added 108.35%	948 $97,000
Q2 2020 Aug 12, 2020	BUY	$55.75 - $92.75 $10,536 - $17,529	189 Added 71.05%	455 $40,000
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $9,778 - $26,945	258 Added 3225.0%	266 $15,000
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $621 - $797	8 New	8 $1,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.